Trials / Completed
CompletedNCT03394352
Exercise Activity-Based Bolus Decisions in Type 1 Diabetes
A Pilot Study of Activity-Based Bolus Decisions in Type 1 Diabetes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- University of Virginia · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to demonstrate safety and feasibility of a decision support system aimed at improving activity-related insulin boluses in Type 1 Diabetes.
Detailed description
Subjects with Type 1 diabetes often need to adjust insulin boluses for activity since activity may increase the chance of hypoglycemia. The aims of this study is to make better bolus decisions by integrating knowledge about daily physical activity (PA) into bolus decisions. It is expected to decrease risk of hypoglycemia related to previous PA and provide better glucose control. The idea is to first obtain a carbohydrate ratio that is optimized around the everyday activity level of the patient and then adjust boluses when the activity for the day is different (above or below) than their regular activity level.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Activity on Board | During the collection phase, the study team will collect information on glucose values, activity measures and insulin settings. This information will be used to determine the meal and correction boluses during the study admission. Subjects will wear a continuous glucose monitor during the data collection phase and study admission. |
| OTHER | Usual Diabetes Care | Subjects will perform their usual diabetes care including basal rate, meal and correction boluses during the study admission. Subjects will wear a continuous glucose monitor during the study admission. |
Timeline
- Start date
- 2018-01-17
- Primary completion
- 2018-05-11
- Completion
- 2018-05-11
- First posted
- 2018-01-09
- Last updated
- 2018-05-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03394352. Inclusion in this directory is not an endorsement.